Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents-Reference-Cited by-同舟云学术

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

Published:2018-07-23 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Kadri Sameer S¹²^ORCID,Adjemian Jennifer³⁴,Lai Yi Ling³,Spaulding Alicen B³,Ricotta Emily³,Prevots D Rebecca³,Palmore Tara N⁵,Rhee Chanu⁶⁷,Klompas Michael⁶⁷,Dekker John P⁸,Powers John H⁹,Suffredini Anthony F¹,Hooper David C²,Fridkin Scott¹⁰,Danner Robert L¹,

Affiliation:

1. Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland

2. Division of Infectious Diseases, Massachusetts General Hospital and Harvard Medical School, Boston

3. Epidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda

4. United States Public Health Service, Commissioned Corps, Rockville

5. National Institutes of Health Clinical Center, Bethesda, Maryland

6. Department of Medicine, Brigham and Women’s Hospital

7. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts

8. Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda

9. Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Maryland

10. Division of Healthcare Quality and Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia

Funder

Agency for Healthcare Research and Quality

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciy378/25202208/ciy378.pdf

Reference31 articles.

1. Antimicrobial resistance: tackling a crisis for the health and wealth of nations;O’Neill

2. Global spread of carbapenemase-producing Enterobacteriaceae;Nordmann;Emerg Infect Dis,2011

3. Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States;McGann;Antimicrob Agents Chemother,2016

4. Emerging infections program as surveillance for antimicrobial drug resistance;Fridkin;Emerg Infect Dis,2015

Cited by 298 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2016-2021);Diagnostic Microbiology and Infectious Disease;2024-02

2. HOCl-producing electrochemical bandage for treating Pseudomonas aeruginosa -infected murine wounds;Antimicrobial Agents and Chemotherapy;2024-01-12

3. Emergence of cefiderocol resistance during ceftazidime/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa;Antimicrobial Agents and Chemotherapy;2024-01-10

4. Descriptive analysis of targeted carbapenemase genes and antibiotic susceptibility profiles among carbapenem-resistant Acinetobacter baumannii tested in the Antimicrobial Resistance Laboratory Network—United States, 2017–2020;Microbiology Spectrum;2024-01-04

5. Focusing on antimicrobial resistant infections –are we missing the forest for the trees and the patients for pathogens?;Frontiers in Antibiotics;2023-12-19